Cardiogenic shock is a critical medical condition characterized by a sudden and severe decrease in the heart's ability to pump blood effectively, leading to insufficient oxygen delivery to vital organs. This condition typically arises from a massive heart attack, severe heart failure, or other cardiac events that compromise the heart's pumping function. As the heart's pumping capacity diminishes, blood pressure drops, and vital organs like the brain, kidneys, and lungs receive inadequate oxygen and nutrients. Common symptoms of cardiogenic shock include rapid breathing, cold and clammy skin, confusion, and a weak pulse. Immediate medical intervention is essential to address the underlying cause and restore blood flow. Treatment may involve medications to support heart function, mechanical support devices, or, in severe cases, emergency interventions such as angioplasty or coronary artery bypass surgery. Prompt recognition and intervention are crucial for improving the chances of survival and minimizing long-term complications associated with cardiogenic shock.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation